OUR SPEAKERS
Safiya Abouzaid, PharmD, MPH
Johnson & Johnson
Vice President, Value, Access, Pricing & Health Care Policy
Suzzette Arnal, PhD
Senior Director, Precision Medicine, Genetics, and Lab Services
US Oncology Network
Edward "Ted" Arrowsmith, MD
Executive Vice President, Therapeutics Tennessee Oncology Medical Director, Pathways
OneOncology
Kristen Boykin, PharmD, BCOP, BCPS
Director of Pharmacy Operations
Florida Cancer Institute and Research Specialists
Ryan Haumschild, PharmD, MS, MBA, CPEL
Vice President of Ambulatory Pharmacy
Emory University and Winship Cancer Institute
David Jackman, MD
Medical Director, Clinical Pathways and New Business Initiatives
Dana-Farber Cancer Institute
Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd
Executive Vice President and Chief Medical Officer
CLL Society, Inc
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics
University of Kansas Cancer Center
Barbara McAneny, MD, FASCO, MACP
Chief Executive Officer
New Mexico Oncology Hematology Consultants Ltd.
Timothy Mok, PharmD, BCOP, BCPS
Manager and Assistant Clinical Professor
Kaiser Permanente & UCSF School of Pharmacy
Ray Parzik, MS
Payment Innovation Leader & Former Payer VBC Executive
Independent, Formerly of Florida Blue, Formerly of The Oncology Institute
Fernanda Polubriaginof, MD, PhD
Associate Chief Health Informatics Officer
Memorial Sloan Kettering Cancer Center
Sucharu "Chris" Prakash, MD
Director Quality Services, Chair Medical Oncology Quality, Medical Director
Texas Oncology
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Vice President of Clinical Innovation
American Oncology Network
Stephen Speicher, MD, MS
Senior Medical Director, Head of Healthcare Quality and Patient Safety
Flatiron Health